Abiraterone acetate
- Product NDC
- 57894-155
- 11-digit product format
- 578940155
- Labeler code
- 57894
- Product ID
- 57894-155_85c1da76-b9c5-4e17-bc0d-7814f644cd4f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Abiraterone acetate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Janssen Biotech, Inc.
- Application
- NDA202379
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2018-02-09
- Marketing end
- 0000-00-00
- Substance
- ABIRATERONE ACETATE
- Active strength
- 250 mg/1
- Pharmacologic classes
- Cytochrome P450 17A1 Inhibitors [MoA],Cytochrome P450 17A1 Inhibitor [EPC],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 57894-155-12 | 57894015512 | 120 TABLET in 1 BOTTLE (57894-155-12) | 120 tablet | 2018-02-09 | 0000-00-00 | No | No | Current |